Search Results - "Lackey, Philip C"
-
1
Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes
Published in BMC infectious diseases (13-02-2023)“…Multi-class resistance, intolerance, and drug-drug interactions can result in unique antiretroviral (ART) combinations for heavily treatment-experienced (HTE)…”
Get full text
Journal Article -
2
Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study
Published in Infectious diseases and therapy (01-03-2020)“…Introduction Dolutegravir (DTG), Elvitegravir (EVG), Raltegravir (RAL) and Darunavir (DRV) are commonly prescribed core agents for antiretroviral therapy…”
Get full text
Journal Article -
3
Immunological and virological response to fostemsavir in routine US clinical care: An OPERA cohort study
Published in HIV medicine (25-08-2024)“…Fostemsavir is a novel attachment inhibitor used with other antiretrovirals in heavily treatment-experienced (HTE) adults with multidrug-resistant HIV-1…”
Get full text
Journal Article -
4
Virologic Outcomes Among People Living With Human Immunodeficiency Virus With High Pretherapy Viral Load Burden Initiating on Common Core Agents
Published in Open forum infectious diseases (01-08-2021)“…Abstract Background People living with human immunodeficiency virus (PLWH) initiating antiretroviral therapy (ART) with viral loads (VLs) ≥100 000 copies/mL…”
Get full text
Journal Article -
5
1264. Durability and effectiveness of fostemsavir in heavily treatment-experienced people with HIV
Published in Open forum infectious diseases (15-12-2022)Get full text
Journal Article